prognostic value of high-sensitivity mrd assessment in cll
Published 3 years ago • 54 plays • Length 2:08Download video MP4
Download video MP3
Similar videos
-
1:19
the prognostic value of mrd in cll
-
1:59
the role of mrd as a prognostic & predictive biomarker in cll
-
1:30
the prognostic value of patient-reported outcomes in mds
-
6:28
prognostic markers and mrd in cll
-
1:11
the prognostic value of ighv mutational status with continuous vs time-limited therapy in cll
-
3:03
the evolution of treatment patterns and prognostic biomarkers in latin american cll patients
-
2:38
importance of prognostic factors in the treatment of cll and how to assess them
-
2:20
adverse prognostic features & treatment response in cll
-
5:03
ighv-mutated vs ighv-unmutated cll | what’s the difference?
-
5:14
eha 2020 cll highlights: cll14 & captivate
-
5:30
considerations of ibrutinib for ighv-unmutated cll
-
3:16
prognostic markers for the treatment of cll
-
2:22
improve study: mrd assessment as an endpoint to define treatment length and intensity in cll
-
1:42
the importance of genomic testing in cll prognosis
-
1:37
the importance of genomic testing in the diagnosis of cll
-
4:46
prediction and prognostication methods for cll
-
1:17
relevance of prognostic factors in the era of targeted therapies in cll
-
2:32
value of mrd measurement in cll
-
2:29
independent prognostic value of total metabolic tumor volume in advanced-stage fl
-
1:04
defining high-risk cll: known and emerging mutations
-
2:52
novel prognostic score for cmml patients undergoing sct
-
1:12
primary analysis of transcend-cll-004: liso-cel in r/r cll